RB1 and small cell lung carcinoma: SCLC is a transcriptionally active disease characterized by common loss‐of‐function genomic alterations in the tumor suppressor genes p53 and RB transcriptional corepressor 1 (RB1), which creates further genomic instability by preventing arrest of the cell cycle required for performing DNA repair [7, 8, 9, 10].